Clinical characteristics and management strategies of lymphoma patients with COVID-19
10.3760/cma.j.issn.1674-2397.2023.04.016
- VernacularTitle:淋巴瘤患者合并COVID-19的临床特征和管理研究进展
- Author:
Xueping DANG
1
;
Shuling HOU
;
Pan CHEN
;
Guiqin WANG
;
Yizhuo CHEN
Author Information
1. 山西医科大学第三医院（山西白求恩医院、山西医学科学院、同济山西医院）淋巴肿瘤科，太原 030032
- Keywords:
COVID-19;
Lymphoma;
Clinical characteristics;
Management
- From:
Chinese Journal of Clinical Infectious Diseases
2023;16(4):315-320
- CountryChina
- Language:Chinese
-
Abstract:
Novel coronavirus has brought great threats to the people and challenges to the health systems around the world. Compared with general population, lymphoma patients are more vulnerable to novel coronavirus infection(COVID-19) and have poorer prognosis. So the clinical management of COVID-19 in lymphoma patients in more difficult and the great importance should be attached. This article reviews the clinical characteristics and current management strategies of lymphoma patients with COVID-19, to provide reference for the clinical treatment of lymphoma patients with COVID-19.
